Archive: 09/10/2012

Better guidelines needed for multimorbidity

New clinical guidelines need to be developed to help doctors provide better care for people with more than one chronic illness, according to a research team led by the University of Dundee.

FDA approves DUCORD product for stem cell transplants

Duke University School of Medicine has received approval from the Food and Drug Administration to market DUCORD, a stem cell product derived from umbilical cord blood, for use in transplants between unrelated donors and recipients.

A study in adaptability: Why do we change our beliefs?

(Medical Xpress)—The human brain likes to make predictions about how the world works. Imagine, for example, that you move to a new town. At first, you don't know where to go for dinner. But after weeks of trying different ...

Australians trial Botox to treat hay fever

The best-selling wrinkle erasing drug Botox will be used in an Australian study to treat hay fever, researchers said Tuesday after it showed promise in providing relief in early trials.

page 9 from 10